We speculate that CD8+ T cells are mobilized fully in the peripheral blood from 48 h to 2 weeks after radiotherapy, preferentially recruited and activated into tumor tissue; in that period, the efficacy of radiotherapy will be enhanced when combined with ICIs. The gene discussed is CD8A; the disease is neoplasm.